ID: MRFR/MED/2220-CR | May 2017 | Region: Global | 83 pages
In the projection period of 2021 to 2028, the dental sleep medicine market will benefit from increased research and development, as well as linked solutions and cloud-based systems, as well as personalized and customized solutions.
Some factors that may impede the growth of the dental sleep medicine market include a lack of patient awareness and expensive treatment prices.
The high cost and scarcity of sleep laboratories, as well as their lack of efficacy and efficiency, would restrict the expansion of the dental sleep medicine market, whereas inadequate standardization, lack of knowledge, and discomfort may provide a challenge to the dental sleep medicine market's growth.
Cumulative Growth Analysis
Unmet medical demands are driving the growth of the dental sleep medication industry. Obstructive sleep apnea affects over 30 million individuals in the United States, according to the American Academy of Dental Sleep Medicine. Sleep is harmed by sedentary lifestyles, extended working hours, noise exposure, and light pollution such as the usage of bright neon lights. Due to its safety, efficiency, and efficacy when compared to procedures and medicines, positive air pressure treatment has the greatest dental sleep medicine market share.
The gold standard in dental sleep medicine diagnosis is polysomnography and respiratory polygraphy. However, because of their simplicity of use, efficiency, and accuracy, the emergence of portable and home-based devices is threatening their market dominance. The primary reason for the increase in efficiency and accuracy is the employment of sophisticated software in these products. Oximetry is more portable and quicker, but the findings are less sensitive and accurate.
Value Chain Analysis
According to the reports, the global dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. Positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices are all part of the treatment section. Polysomnography and respiratory polygraphy, home oximetry, and actigraphy are all part of the diagnostics section. The dental sleep medicine market is divided into three categories based on the end-user: hospitals, sleep labs, and homes. In 2016, the treatment segment had the biggest dental sleep medicine global market share of 61.42 percent, and it is anticipated to increase at a CAGR of 8.74 percent from 2016 to 2022. In 2016, hospitals and sleep laboratories had the biggest dental sleep medicine global market share of 57.1 percent, while North America had the largest market share of USD 2,849.44 million.
Dental sleep medicine global market, by region 2016 & 2023 (market value)
The dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. The global dental sleep medicine market is expected to witness decent growth during the forecast period.
Based on the application, the dental sleep medicine market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices.
Based on the propulsion types, the dental sleep medicine market is segmented into hospitals, sleep labs, and homes.
According to the reports, on the basis of region, the global dental sleep medicine market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America was the world's largest market for dental sleep medicine. Because of its high per capita income, superior reimbursement policies for medical equipment, and larger healthcare industry, the United States leads the North American market. The expansion of the North American market is also fueled by the concentration of major medical device makers in the United States. In 2016, Europe was the world's second-largest market for dental sleep medicine. The emerging regions, notably the Asia Pacific and the Middle East, and Africa, are projected to see the greatest growth for high-tech and low-tech dental sleep medication products throughout the projection period due to huge unmet demand.
The global dental sleep medicine market is highly fragmented due to the presence of prominent players in the market. Mergers, R&D, partnerships, and other tactics used by market players to get a foothold in this Market organizations are examples of specific methods used by market players to gain a foothold in the Dental Sleep Medicine Market.
Major Key Players
The following report comprises of –
By Treatment & Diagnostics
By End User
|Market Size||2027: Significant Value|
|CAGR||2016-2022: 8.74 %|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Treatment, Diagnostics and End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company|
|Key Market Opportunities||
|Key Market Drivers||Unmet medical needs and rising prevalence of sleep apnea|
Frequently Asked Questions (FAQ) :
North America is predicted to lead the Dental Sleep Medicine Market.
Sleep laboratories and hospitals will dominate the Dental Sleep Medicine Market.
Unmet medical needs and rising prevalence of sleep apnea are boosting market growth.
High treatment cost may limit market growth.
Specific strategies adopted by market players to create a foothold in the Dental Sleep Medicine Market include mergers, R&D, collaborations, and others.